Disease Indications: Multiple Myeloma

Manufacturer: Janssen-Cilag International N.V.

Usage: Intravenous

Medicine approved by:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Darzalex (daratumumab) is a monoclonal antibody used to treat multiple myeloma by targeting the CD38 protein on myeloma cells. The drug is approved by the FDA and may be used alone or in combination with other medications.